Tandem Health henter inn 50 millioner dollar for å bygge et AI-drevet operativsystem for kliniske arbeidsflyter.
Les kunngjøringen →
September 17, 2025
We are pleased to welcome Cristina Stenbeck to our board. As Chairman of the Board at Kinnevik, Cristina will represent Kinnevik after leading the Series A financing round in June.
Cristina and the wider team at Kinnevik will provide expertise and deep knowledge to enable us to continue on our mission to build and design a fully AI native operating system that will improve workflows for clinicians across Europe.
“After spending time with Cristina and the Kinnevik team pre-investment it was clear that the breadth of the expertise among management and the depth of the healthcare knowledge from the investment team members would be of enormous value to Tandem. Kinnevik has a decade long track record investing in the healthcare sector in the likes of Livongo and Spring Health. Cristina has also worked with and invested in European growth companies for two decades, serving om the boards of champions such as Spotify and Zalando. We are very much looking forward to continuing to partner with Kinnevik via Cristina, Georgi, Tatiana, Christian and the broader team.” says Lukas Saari, CEO of Tandem.
“As Chairman of Kinnevik, it’s natural for me to engage with our portfolio companies and to bring what is needed whether it is experience, ideas, contacts or the learnings from all my many mistakes in helping to build enduring fast-growing companies. Kinnevik has always been an active owner, and with 20 years spent on private and public Boards like Zalando and Spotify, combined with Kinnevik’s relevant track record of building SaaS companies in healthcare, I believe we can be helpful to Tandem’s founding team Lukas, Oscar, and Oliver in their continued expansion in Europe.”, says Cristina Stenbeck, Chair of Kinnevik.
Cristina was elected to the Board by Shareholders at Tandem's Extraordinary General Meeting (EGM) held on 15 September 2025, and the Board met yesterday.
Tandem Health is a European healthtech company building the complete AI medical assistant for clinicians. Trusted by more than 1,000 healthcare organisations across Europe, Tandem helps clinicians cut their documentation time by up to two hours per day. Built by clinicians for clinicians, our technology reduces admin, restores focus on patients, and supports better care across every consultation.
Kinnevik is a leading growth investor on a mission to redefine industries and create remarkable growth companies. We are an active owner and operational partner, providing patient capital to challenger technology-enabled businesses in Europe and the US. Our passionate founders are building tomorrow’s leaders within healthcare, software and climate, making everyday life easier and better for people around the world. We invest at all stages of a company’s growth journey, always determined to create long-term value. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.
